LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

LLY

1,024.93

+1.7%↑

JNJ

211.32

+0.84%↑

ABBV

222.39

-0.23%↓

UNH

341.33

+1.48%↑

AZN

89.83

-0.92%↓

Home・Akciju saraksts・Talphera Inc.

Talphera Inc.

Slēgts

1.16 -1.69

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.16

Max

1.26

Galvenie mērījumi
By Trading Economics
Darbinieki	13

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+160% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-9.6M 51M
Iepriekšējā atvēršanas cena	2.85
Iepriekšējā slēgšanas cena	1.16

Talphera Inc. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 11. dec. 23:58 UTC

Iegādes, apvienošanās, pārņemšana

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

2025. g. 11. dec. 23:56 UTC

Peļņas

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

2025. g. 11. dec. 23:03 UTC

Iegādes, apvienošanās, pārņemšana

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

2025. g. 11. dec. 22:06 UTC

Iegādes, apvienošanās, pārņemšana

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

2025. g. 11. dec. 21:50 UTC

Peļņas

Costco Same-Store Sales, Membership Fees Rose in 1Q

2025. g. 11. dec. 23:45 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 11. dec. 23:44 UTC

Tirgus saruna

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

2025. g. 11. dec. 23:37 UTC

Tirgus saruna

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

2025. g. 11. dec. 23:31 UTC

Peļņas

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

2025. g. 11. dec. 22:48 UTC

Iegādes, apvienošanās, pārņemšana

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

2025. g. 11. dec. 22:35 UTC

Peļņas

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

2025. g. 11. dec. 22:30 UTC

Peļņas

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

2025. g. 11. dec. 22:09 UTC

Iegādes, apvienošanās, pārņemšana

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

2025. g. 11. dec. 22:06 UTC

Iegādes, apvienošanās, pārņemšana

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

2025. g. 11. dec. 22:05 UTC

Peļņas

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

2025. g. 11. dec. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

2025. g. 11. dec. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 11. dec. 21:39 UTC

Peļņas

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

2025. g. 11. dec. 21:39 UTC

Peļņas

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

2025. g. 11. dec. 21:38 UTC

Peļņas

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

2025. g. 11. dec. 21:37 UTC

Peļņas

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

2025. g. 11. dec. 21:37 UTC

Tirgus saruna

Broadcom Sees AI Revenue Doubling -- Market Talk

2025. g. 11. dec. 21:34 UTC

Iegādes, apvienošanās, pārņemšana

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

2025. g. 11. dec. 21:29 UTC

Iegādes, apvienošanās, pārņemšana

Dexus Aiming for Long-Term Holding of A$50M in Fund

2025. g. 11. dec. 21:28 UTC

Tirgus saruna

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

2025. g. 11. dec. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

Dexus Expects to Introduce Additional Third-Party Equity in FY26

2025. g. 11. dec. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

Dexus: Third Party Investors to Contribute Remainder

2025. g. 11. dec. 21:27 UTC

Iegādes, apvienošanās, pārņemšana

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

2025. g. 11. dec. 21:26 UTC

Iegādes, apvienošanās, pārņemšana

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

2025. g. 11. dec. 21:25 UTC

Iegādes, apvienošanās, pārņemšana

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Salīdzinājums

Cenas izmaiņa

Talphera Inc. Prognoze

Cenas mērķis

By TipRanks

160% augšup

Prognoze 12 mēnešiem

Vidējais 3.25 USD 160%

Augstākais 3.5 USD

Zemākais 3 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Talphera Inc. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Talphera Inc. — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Par Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.